1. Home
  2. COOP vs LNTH Comparison

COOP vs LNTH Comparison

Compare COOP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COOP
  • LNTH
  • Stock Information
  • Founded
  • COOP 1994
  • LNTH 1956
  • Country
  • COOP United States
  • LNTH United States
  • Employees
  • COOP N/A
  • LNTH N/A
  • Industry
  • COOP Finance: Consumer Services
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • COOP Finance
  • LNTH Health Care
  • Exchange
  • COOP Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • COOP 8.2B
  • LNTH 7.5B
  • IPO Year
  • COOP N/A
  • LNTH 2015
  • Fundamental
  • Price
  • COOP $149.12
  • LNTH $79.19
  • Analyst Decision
  • COOP Buy
  • LNTH Strong Buy
  • Analyst Count
  • COOP 8
  • LNTH 5
  • Target Price
  • COOP $130.14
  • LNTH $133.80
  • AVG Volume (30 Days)
  • COOP 915.2K
  • LNTH 1.0M
  • Earning Date
  • COOP 07-24-2025
  • LNTH 07-30-2025
  • Dividend Yield
  • COOP N/A
  • LNTH N/A
  • EPS Growth
  • COOP N/A
  • LNTH N/A
  • EPS
  • COOP 8.81
  • LNTH 3.53
  • Revenue
  • COOP $2,221,000,000.00
  • LNTH $1,536,699,000.00
  • Revenue This Year
  • COOP $19.78
  • LNTH $4.63
  • Revenue Next Year
  • COOP $11.71
  • LNTH $9.35
  • P/E Ratio
  • COOP $16.40
  • LNTH $22.44
  • Revenue Growth
  • COOP 9.52
  • LNTH 12.53
  • 52 Week Low
  • COOP $78.20
  • LNTH $73.11
  • 52 Week High
  • COOP $151.48
  • LNTH $126.89
  • Technical
  • Relative Strength Index (RSI)
  • COOP 68.12
  • LNTH 44.57
  • Support Level
  • COOP $138.83
  • LNTH $76.34
  • Resistance Level
  • COOP $147.23
  • LNTH $84.36
  • Average True Range (ATR)
  • COOP 6.11
  • LNTH 2.69
  • MACD
  • COOP 0.86
  • LNTH 0.66
  • Stochastic Oscillator
  • COOP 91.32
  • LNTH 48.07

About COOP Mr. Cooper Group Inc.

Mr. Cooper Group Inc is a home loan servicer. The company focuses on delivering a variety of servicing and lending products. It has operating segments namely Servicing segment which performs operational activities on behalf of investors or owners of the underlying mortgages and mortgage servicing rights, including collecting and disbursing borrower payments, investor reporting, and customer service, The Originations segment originates residential mortgage loans through a direct-to-consumer channel, which provides refinance options for existing customers, and through a correspondent channel, which purchases or originates loans from mortgage bankers and brokers, and the Corporate segment. The Servicing segment of the company generates maximum revenue.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: